SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-19-000048
Filing Date
2019-03-07
Accepted
2019-03-07 14:44:23
Documents
1
Period of Report
2018-10-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 2985
  Complete submission text file 0001250853-19-000048.txt   4843
Mailing Address 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE CA 90503 310-214-0065
EMMAUS LIFE SCIENCES, INC. (Issuer) CIK: 0001420031 (see all company filings)

IRS No.: 412254389 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address S-TOWER 14TH FLOOR, 469 BONGUNSA-RO SEOUL M5 06141
Business Address S-TOWER 14TH FLOOR, 469 BONGUNSA-RO SEOUL M5 06141 02-515-8808
Telcon RF Pharmaceutical Inc. (Reporting) CIK: 0001738761 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-53072 | Film No.: 19665490